Table 4.
Compound | IC50 (µM) a | |
---|---|---|
HepG2 | Hela | |
5 | 59.14 ± 15.79 | 5.82 ± 0.82 |
1–4, 6–11 | - | - |
Adriamycin b | - | 0.95 ± 0.61 |
Fluorouracil c | 176 ± 28.8 | - |
a Data are presented as mean ± SD from three separate experiments. b Hela cell positive control. c Hepg2 cell positive control. ‘-’ stands for no inhibitory effect at 200 µM.